Plasma viral MicroRNA profiles reveal potential biomarkers for chronic active epstein-barr virus infection

Journal of Infectious Diseases

Volumn 208, Issue 5, 2013, Pages 771-779

  Kawano, Yoshihiko ^a   Iwata, Seiko ^a   Kawada, Jun Ichi ^a   Gotoh, Kensei ^b   Suzuki, Michio ^a   Torii, Yuka ^a   Kojima, Seiji ^a   Kimura, Hiroshi ^a   Ito, Yoshinori ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Welfare Federation of Agricultural Cooperatives   (Japan)

Author keywords

biomarker; chronic active Epstein Barr virus infection; Epstein Barr virus; microRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA BAMHI A REGION RIGHTWARD TRANSCRIPT 1 5P; MICRORNA BAMHI A REGION RIGHTWARD TRANSCRIPT 13; MICRORNA BAMHI A REGION RIGHTWARD TRANSCRIPT 15; MICRORNA BAMHI A REGION RIGHTWARD TRANSCRIPT 2 5P; MICRORNA BAMHI A REGION RIGHTWARD TRANSCRIPT 22; MICRORNA BAMHI A REGION RIGHTWARD TRANSCRIPT 4; MICRORNA BAMHI A REGION RIGHTWARD TRANSCRIPT 7; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ADOLESCENT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; MALE; OPEN READING FRAME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY; SCHOOL CHILD; VIRUS LOAD;

BIOMARKER; CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION; EPSTEIN-BARR VIRUS; MICRORNA;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; MALE; MICRORNAS; MIDDLE AGED; PLASMA; RNA, VIRAL; YOUNG ADULT;

EID: 84881631532     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit222     Document Type: Article

References (48)

1. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343: 481-92.
2. Williams H, Crawford DH. Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood 2006; 107:862-9.
3. Tosato G, Straus S, Henle W, Pike SE, Blaese RM. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol 1985; 134:3082-8.
4. Kimura H. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001; 98:280-6.
5. Jones JF, Shurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988; 318:733-41.
6. Kikuta H, Taguchi Y, Tomizawa K, et al. Epstein-Barr virus genomepositive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 1988; 333:455-7.
7. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989; 84:51-5.
8. Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003; 187: 527-33.
9. Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency Rev Med Virol 2006; 16:251-61.
10. Cohen JI, Jaffe ES, Dale JK, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 2011; 117:5835-49.
11. Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 2012; 119:673-86.
12. Gotoh K, Ito Y, Shibata-Watanabe Y, et al. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis 2008; 46:1525-34.
13. Okamura T, Hatsukawa Y, Arai H, Inoue M, Kawa K. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet 2000; 356:223-4.
14. Kawa K, Sawada A, Sato M, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant 2011; 46: 77-83.
15. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33.
16. Mattick JS, Makunin IV. Small regulatory RNAs in mammals. Hum Mol Genet 2005; 14(Spec No 1):R121-32.
17. Cai X, Schafer A, Lu S, et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2006; 2: e23.
18. Cosmopoulos K, Pegtel M, Hawkins J, et al. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 2009; 83:2357-67.
19. Grundhoff A, Sullivan CS, Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006; 12:733-50.
20. Pfeffer S, Zavolan M, Grasser FA, et al. Identification of virus-encoded microRNAs. Science 2004; 304:734-6.
21. Zhu JY, Pfuhl T, Motsch N, et al. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 2009; 83:3333-41.
22. Barth S, Meister G, Grasser FA. EBV-encoded miRNAs. Biochim Biophys Acta 2011; 1809:631-40.
23. Qiu J, Cosmopoulos K, Pegtel M, et al. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 2011; 7:e1002193.
24. Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 2010; 10:297-308.
25. Brase JC, Wuttig D, Kuner R, Sultmann H. Serum microRNAs as noninvasive biomarkers for cancer. Mol Cancer 2010; 9:306.
26. Moussay E,Wang K, Cho JH, et al. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2011; 108:6573-8.
27. Gourzones C, Gelin A, Bombik I, et al. Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol J 2010; 7:271.
28. Kimura H, Morita M, Yabuta Y, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37:132-6.
29. Edwards RH, Marquitz AR, Raab-Traub N. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 2008; 82:9094-106.
30. Amoroso R, Fitzsimmons L, Thomas WA, Kelly GL, Rowe M, Bell AI. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation. J Virol 2011; 85:996-1010.
31. Zhang Y, Nagata H, Ikeuchi T, et al. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniformelike eruptions. Br J Haematol 2003; 121:805-14.
32. Tsuge I, Morishima T, Morita M, Kimura H, Kuzushima K, Matsuoka H. Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line. Clin Exp Immunol 1999; 115:385-92.
33. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33: e179.
34. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36:D154-8.
35. Wada K, Kubota N, Ito Y, et al. Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol 2007; 45:1426-32.
36. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105:10513-8.
37. Chan JY, Gao W, Ho WK, Wei WI, Wong TS. Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma. Anticancer Res 2012; 32:3201-10.
38. Xia T, O'Hara A, Araujo I, et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 2008; 68:1436-42.
39. Xing L, Kieff E. Epstein-Barr virus BHRF1 micro-and stable RNAs during latency III and after induction of replication. J Virol 2007; 81:9967-75.
40. Iwata S, Wada K, Tobita S, et al. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection. J Gen Virol 2010; 91:42-50.
41. Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 2009; 386:387-97.
42. Chen SJ, Chen GH, Chen YH, et al. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One 2010; 5:e12745.
43. Barth S, Pfuhl T, Mamiani A, et al. Epstein-Barr virus-encoded micro-RNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 2008; 36:666-75.
44. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 2009; 5:376-85.
45. Choy EY, Siu KL, Kok KH, et al. An Epstein-Barr virus-encoded micro-RNA targets PUMA to promote host cell survival. J Exp Med 2008; 205:2551-60.
46. Lung RW, Tong JH, Sung YM, et al. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miRBART22. Neoplasia 2009; 11:1174-84.
47. Yamamoto M, Kimura H, Hironaka T, et al. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol 1995; 33:1765-8.
48. Kanegane H, Wakiguchi H, Kanegane C, Kurashige T, Miyawaki T, Tosato G. Increased cell-free viral DNA in fatal cases of chronic active Epstein-Barr virus infection. Clin Infect Dis 1999; 28:906-9.